(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 7.1% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.63%.
Bruker's revenue in 2023 is $2,505,800,000.On average, 5 Wall Street analysts forecast BRKR's revenue for 2023 to be $394,725,612,233, with the lowest BRKR revenue forecast at $386,548,106,944, and the highest BRKR revenue forecast at $398,491,224,133.
In 2024, BRKR is forecast to generate $426,258,530,349 in revenue, with the lowest revenue forecast at $420,241,817,358 and the highest revenue forecast at $432,452,625,105.